Datycs CEO on Transforming Unstructured Clinical Data into Real-Time Healthcare Intelligence

How do you turn messy, unstructured healthcare data into real-time intelligence that actually improves care? In this podcast hosted by Mphasis Vice President of Products Chenny Solaiyappan, Datycs CEO Dr. Srini Rao speaks on transforming unstructured clinical data into real-time healthcare intelligence. The conversation explores interoperability, NLP versus GenAI in regulated environments, and why real progress in value-based care depends on transforming clinical notes into actionable, standards-based data.

Subscribe to the Product Talk podcast on Spotify and Apple Podcasts and catch every conversation with leading product executives.

---

---

LISTEN ON ITUNES

---

LISTEN ON SPOTIFY

---

---

Show Notes

1. Srini Rao’s career spans major technological revolutions: speech recognition and machine learning at IBM, wireless at Motorola, and healthcare AI.
2. His entrepreneurial mindset was shaped by his early startup experience, which later led to Motorola’s acquisition.
3. Transition to healthcare was motivated both by technological opportunity (big data, sensors) and personal/family ties.
4. Datex was founded to address the challenge of transforming unstructured healthcare data into actionable intelligence.
5. The company leverages NLP and machine learning to extract valuable insights from messy, unstructured clinical data.
6. Unlike many competitors, Datex’s focus is on real, messy clinical notes rather than only structured healthcare data.
7. Datex has processed over 15 million clinical charts, gaining extensive exposure to diverse data sets.
8. They partner with organizations such as the Massachusetts Health Data Consortium to enable real-time, FHIR-based data exchange for better interoperability.
9. Interoperability in healthcare is compared to similar challenges in telecom—slow progress, many silos, and the need for common standards.
10. Adoption of FHIR API and transforming unstructured docs into FHIR resources are central to Datex’s approach.
11. There are significant business model challenges due to healthcare’s fragmented ecosystem and slow adoption cycles.
12. Datex’s initial product summarized patient charts to give clinicians single-view access to key patient information.
13. Their services expanded from summarization to document processing for quality reporting, risk adjustment, and prior authorization automation.
14. The company frequently reassesses market direction—waiting for sufficient, real market demand before scaling new solutions.
15. Fine-tuning or building healthcare-specific language models (small language models/SLMs) is still an open challenge, with industry limitations and data access restrictions.
16. Customer needs and market trends shape product prioritization, ensuring resource-constrained startups avoid spreading themselves too thin.
17. The “desirability, feasibility, viability” framework drives solution development and prioritization at Datex.
18. For entrepreneurs: focus on real, concrete problems and plan for a long-term journey in healthcare tech.
19. AI is expected to play a transformative role not only in care delivery, but also in research and clinical trials through real-world evidence.
20. Continuous adaptation, partnership, and learning are essential to succeeding in healthcare innovation.